Application no. and date | 14712628.8 (espacenet) (Federated) (European Patent Register), 20140317 | Patent/reg. no. and date | DK/EP 2972368, 20190724 | Publication date | 20160120 | Priority no. and date | EP 13382091, 20130315 | EP pub. no. and date |
EP 2972368 20160120 | Effective date | | Applicant/owner | TIGENIX N.V., Haarsrode Research Park 1724 Romeinse straat 12 bus 2
3001 Leuven, BE, TiGenix, S.A.U., Parque Tecnológico de Madrid C/ Marconi, 1
28760 Tres Cantos (Madrid), ES | Applicant ref. no. | P69640DK01 | Inventor | DALEMANS, Wilfried, Tigenix NV Romeinse straat 12 bus 2
B-3001 Leuven, BE, DE LA ROSA, Olga, TiGenix S.A.U Parque Tecnológico de Madrid Marconi 1
E-28760 Tres Cantos - Madrid, ES, LOMBARDO, Eleuterio, TiGenix S.A.U Parque Tecnológico de Madrid Marconi 1
E-28760 Tres Cantos - Madrid, ES | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | G01N 33/569 (2006.01) | Title | LYMFOCYTBIOMARKØRER TIL AT BESTEMME DET KLINISKE RESPONS PÅ CELLETERAPI | Int. application no. | EP2014055282 | Int. publication no. | WO2014140362 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|